IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-34025-x.html
   My bibliography  Save this article

Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology

Author

Listed:
  • James M. Dolezal

    (University of Chicago Medical Center)

  • Andrew Srisuwananukorn

    (Icahn School of Medicine at Mount Sinai)

  • Dmitry Karpeyev

    (DV Group, LLC)

  • Siddhi Ramesh

    (University of Chicago Medical Center)

  • Sara Kochanny

    (University of Chicago Medical Center)

  • Brittany Cody

    (University of Chicago)

  • Aaron S. Mansfield

    (Mayo Clinic)

  • Sagar Rakshit

    (Mayo Clinic)

  • Radhika Bansal

    (Mayo Clinic)

  • Melanie C. Bois

    (Mayo Clinic)

  • Aaron O. Bungum

    (Mayo Clinic)

  • Jefree J. Schulte

    (University of Wisconsin at Madison)

  • Everett E. Vokes

    (University of Chicago Medical Center)

  • Marina Chiara Garassino

    (University of Chicago Medical Center)

  • Aliya N. Husain

    (University of Chicago)

  • Alexander T. Pearson

    (University of Chicago Medical Center)

Abstract

A model’s ability to express its own predictive uncertainty is an essential attribute for maintaining clinical user confidence as computational biomarkers are deployed into real-world medical settings. In the domain of cancer digital histopathology, we describe a clinically-oriented approach to uncertainty quantification for whole-slide images, estimating uncertainty using dropout and calculating thresholds on training data to establish cutoffs for low- and high-confidence predictions. We train models to identify lung adenocarcinoma vs. squamous cell carcinoma and show that high-confidence predictions outperform predictions without uncertainty, in both cross-validation and testing on two large external datasets spanning multiple institutions. Our testing strategy closely approximates real-world application, with predictions generated on unsupervised, unannotated slides using predetermined thresholds. Furthermore, we show that uncertainty thresholding remains reliable in the setting of domain shift, with accurate high-confidence predictions of adenocarcinoma vs. squamous cell carcinoma for out-of-distribution, non-lung cancer cohorts.

Suggested Citation

  • James M. Dolezal & Andrew Srisuwananukorn & Dmitry Karpeyev & Siddhi Ramesh & Sara Kochanny & Brittany Cody & Aaron S. Mansfield & Sagar Rakshit & Radhika Bansal & Melanie C. Bois & Aaron O. Bungum & , 2022. "Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34025-x
    DOI: 10.1038/s41467-022-34025-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-34025-x
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-34025-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Stephen-John Sammut & Mireia Crispin-Ortuzar & Suet-Feung Chin & Elena Provenzano & Helen A. Bardwell & Wenxin Ma & Wei Cope & Ali Dariush & Sarah-Jane Dawson & Jean E. Abraham & Janet Dunn & Louise H, 2022. "Multi-omic machine learning predictor of breast cancer therapy response," Nature, Nature, vol. 601(7894), pages 623-629, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Dani Kiyasseh & Aaron Cohen & Chengsheng Jiang & Nicholas Altieri, 2024. "A framework for evaluating clinical artificial intelligence systems without ground-truth annotations," Nature Communications, Nature, vol. 15(1), pages 1-14, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mattia Rediti & Aranzazu Fernandez-Martinez & David Venet & Françoise Rothé & Katherine A. Hoadley & Joel S. Parker & Baljit Singh & Jordan D. Campbell & Karla V. Ballman & David W. Hillman & Eric P. , 2023. "Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    2. Umberto Perron & Elena Grassi & Aikaterini Chatzipli & Marco Viviani & Emre Karakoc & Lucia Trastulla & Lorenzo M. Brochier & Claudio Isella & Eugenia R. Zanella & Hagen Klett & Ivan Molineris & Julia, 2024. "Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    3. Khoa A. Tran & Venkateswar Addala & Rebecca L. Johnston & David Lovell & Andrew Bradley & Lambros T. Koufariotis & Scott Wood & Sunny Z. Wu & Daniel Roden & Ghamdan Al-Eryani & Alexander Swarbrick & E, 2023. "Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    4. Yuan Gao & Sofia Ventura-Diaz & Xin Wang & Muzhen He & Zeyan Xu & Arlene Weir & Hong-Yu Zhou & Tianyu Zhang & Frederieke H. Duijnhoven & Luyi Han & Xiaomei Li & Anna D’Angelo & Valentina Longo & Zaiyi, 2024. "An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    5. Joyce V. Lee & Filomena Housley & Christina Yau & Rachel Nakagawa & Juliane Winkler & Johanna M. Anttila & Pauliina M. Munne & Mariel Savelius & Kathleen E. Houlahan & Daniel Mark & Golzar Hemmati & G, 2022. "Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer," Nature Communications, Nature, vol. 13(1), pages 1-12, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34025-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.